Structure and flexibility of the yeast NuA4 histone acetyltransferase complex

  1. Stefan A Zukin
  2. Matthew R Marunde
  3. Irina K Popova
  4. Katarzyna M Soczek
  5. Eva Nogales  Is a corresponding author
  6. Avinash B Patel  Is a corresponding author
  1. Harvard University, United States
  2. EpiCypher, United States
  3. University of California, Berkeley, United States
  4. Lawrence Berkeley National Laboratory, United States
  5. Northwestern University, United States

Abstract

The NuA4 protein complex acetylates histones H4 and H2A to activate both transcription and DNA repair. We report the 3.1 Å-resolution cryo-electron microscopy structure of the central hub of NuA4, which flexibly tethers the HAT and TINTIN modules. The hub contains the large Tra1 subunit and a core that includes Swc4, Arp4, Act1, Eaf1 and the C-terminal region of Epl1. Eaf1 stands out as the primary scaffolding factor that interacts with the Tra1, Swc4 and Epl1 subunits and contributes the conserved HSA helix to the Arp module. Using nucleosome binding assays, we find that the HAT module, which is anchored to the core through Epl1, recognizes H3K4me3 nucleosomes with hyperacetylated H3 tails, while the TINTIN module, anchored to the core via Eaf1, recognizes nucleosomes that have hyperacetylated H2A and H4 tails. Together with the known interaction of Tra1 with site-specific transcription factors, our data suggests a model in which Tra1 recruits NuA4 to specific genomic sites then allowing the flexible HAT and TINTIN modules to select nearby nucleosomes for acetylation.

Data availability

The cryo-EM maps and coordinate models have been deposited in the Electron Microscopy Data Bank with the accession codes EMD-28575 (NuA4 full), EMD-28563 (NuA4 core), EMD-28565 (NuA4 Tra1-FATKIN), EMD-28566 (Tra1-HEAT), EMD-28568 (Tra1-HEAT-top), EMD-28569 (Tra1-HEAT-middle), EMD-28567 (Tra1-HEAT-bottom) and in the Protein Data Bank with the accession codes PDB-8ESC (NuA4). Plasmids for HAT and TINTIN expression have been made available through Addgene (Catalog #193325 (S.c. NuA4 HAT) and #193326 (S.c NuA4 TINTIN)).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Stefan A Zukin

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
  2. Matthew R Marunde

    EpiCypher, Durham, United States
    Competing interests
    Matthew R Marunde, EpiCypher is a commercial developer and supplier of reagents (e.g. PTM-defined semi-synthetic nucleosomes; dNucs) and platforms (dCypher®) used in this study..
  3. Irina K Popova

    EpiCypher, Durham, United States
    Competing interests
    Irina K Popova, EpiCypher is a commercial developer and supplier of reagents (e.g. PTM-defined semi-synthetic nucleosomes; dNucs) and platforms (dCypher®) used in this study..
  4. Katarzyna M Soczek

    California Institute for Quantitative Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Eva Nogales

    Molecular Biophysics and Integrative Bio-Imaging Division, Lawrence Berkeley National Laboratory, Berkeley, United States
    For correspondence
    enogales@lbl.gov
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9816-3681
  6. Avinash B Patel

    Molecular Biosciences, Northwestern University, Evanston, United States
    For correspondence
    avinash.patel@northwestern.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9140-8375

Funding

National Institute of General Medical Sciences (R35-GM127018)

  • Stefan A Zukin
  • Eva Nogales
  • Avinash B Patel

National Institute of General Medical Sciences (R44GM117683)

  • Matthew R Marunde
  • Irina K Popova

National Institute of General Medical Sciences (R44GM116584)

  • Matthew R Marunde
  • Irina K Popova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,464
    views
  • 321
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stefan A Zukin
  2. Matthew R Marunde
  3. Irina K Popova
  4. Katarzyna M Soczek
  5. Eva Nogales
  6. Avinash B Patel
(2022)
Structure and flexibility of the yeast NuA4 histone acetyltransferase complex
eLife 11:e81400.
https://doi.org/10.7554/eLife.81400

Share this article

https://doi.org/10.7554/eLife.81400

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

    1. Structural Biology and Molecular Biophysics
    Manming Xu, Sarath Chandra Dantu ... Shozeb Haider
    Research Article

    The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.